ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626540 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626540; 2) Community: the network communities that were significantly associated with the response to NSC 626540; 3) Molecule: the relationships between components within communities and NSC 626540; 4) MDR: the compounds that were significantly associated with the NSC 626540.

NSC Compound Enrichment Correlation
NSC 113951 6-Bromotoyocamycin 0.0244632509325736 0.53696498
NSC 135371 Null 0.0244632509325736 0.57450012
NSC 138333 Null 0.0244632509325736 0.44603929
NSC 194618 Benz[a]anthracene-7,12-dione, 1,8-dihydroxy-3-methyl- (7CI, 8CI, 9CI) 0.0244632509325736 0.11644525
NSC 26273 6-Benzylthioinosine 0.0244632509325736 0.44921001
NSC 36437 14-Oxabicyclo[11.3.1]heptadeca-4,8-dien-15-one, 2-(acetyloxy)-12-hydroxy-4,8,12-trimethyl-16-methylene-, [1S(1R*,2R*,4Z,8Z,12S*,13R*)]- (9CI) 0.0244632509325736 0.40997086
NSC 380721 Eremantholide B 0.0244632509325736 0.3002487
NSC 609699 Topotecan hydrochloride 0.0244632509325736 0.44005209
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0244632509325736 0.2900539
NSC 628911 3-(2-N,N-diethylaminoethylamino)-7-nitro-1,2,4- benzotriazine 1,4-dioxide. Trifluoroacetate 0.0244632509325736 0.63619797
Total:149  Current:98    [First] [Prev] [Next] [Last]